Oppimi proposes a complete solution to help diagnose and support an efficient Dysgraphia Treatment

Pilot with Finland Torkinmäki school
We are glad to announce the formalisation of our collaboration in Finland with Kokkola school Torkinmäki, Microsoft Flux and OppimiGroup.
New collaboration with TimeLink China
Oppimi and TimeLink are taking the next step forward in the future of Education technology and in learning disability diagnosis and treatment process.
CEEIA Chengdu 2018
Oppimi will present at the Western China International Expo Center in Chengdu from May 11th to 13th, 2018
Big Data
Big Data is key to Health Development, accelerate Research is one objective for Oppimi

LEARNING DISABILITIES DIGITAL SOLUTIONS

Pilot with Finland Torkinmäki school
We are glad to announce the formalisation of our collaboration in Finland with Kokkola school Torkinmäki, Microsoft Flux and OppimiGroup.
New collaboration with TimeLink China
Oppimi and TimeLink are taking the next step forward in the future of Education technology and in learning disability diagnosis and treatment process.
CEEIA Chengdu 2018
Oppimi will present at the Western China International Expo Center in Chengdu from May 11th to 13th, 2018
Big Data
Big Data is key to Health Development, accelerate Research is one objective for Oppimi

Innovative Learning Disabilities diagnosis and therapy process through AI and Gamification

VISION & PHILOSOPHY

At Oppimi we are using AI for creating innovative clinically-validated Digital Health Tools for diagnosing and treating children that are affected by learning disabilities, through video game environments.

Making test and therapy for learning disabilities as Dysgraphia, Dyslexia, Dyscalculia more efficient, easier and funnier is our main goal!

OUR APPROACH

We are providing a full ecosystem that connects learning disabilities specialists, teachers and children’s parents, while given them access to test content and results, therapy advancement details and high-quality analytics.

World is moving fast and taking advantage of big data and sharing platforms can drastically fasten research and benefits children, families and science.

WORLDWIDE PRESENCE

PARTNERS

ACHIEVMENTS

October 8 2019

Outputs of AIRIPA Congress

Oppimi Group attended AIRIPA congress (Italian Association for Research and Intervention in Learning Psychopathology) last 26th September. Our 2 collaboration partners, Vimercate Hospital and University of Parma, shared compelling opinions on the use of Oppimi Console for the diagnosis and the therapy of dysgraphia through the release of 2 publications.

Here are some extract of these documents.

In this first experimental phase, Oppimi tablet tool has proven to be sensitive to the normal learning process, showing an improvement in the copying test in italics during the second experimental phase.
University of Parma
From the diagnostic point of view, Oppimi’s tool was sensitive in the discrimination of children with graphomotor difficulties, proving to be a contribution to the diagnostic process.
Vimercate Hospital

January 16 2019

Capital increase to support second phase of clinical piloting

Oppimi Group announces a capital increase in the form of a private placement. This capital increase by Wygu Investment Holdings Co. Limited comes 12 months after the entry of Pu Ying Olicom Technology Hong Kong Limited as a private investor, and aims to finance the second phase of clinical piloting of his digital ecosystem.

About Oppimi

Oppimi believes that supporting schools with innovative screening tools for early identification of learning disabilities can set struggling students on a path of success. Oppimi helps doctors by providing a high performance evaluating scale, clinically validated, that increases the diagnostic accuracy and drastically reduces the time dedicated to calculations and reports.

Oppimi supports test and treatment for children affected by learning disabilities with innovative diagnosis and therapy digital products through AI and Gamification. We are using AI for creating clinically-validated Digital Health Products for diagnosing and treating children that are affected by learning disabilities.

Ai is changing drastically how health is approching LDs, and we are enbracing big data as core. Oppimi’s algorithms, based on machine learning techniques, are able to monitor patient’s advancements and suggest new tasks for optimizing the training results. We are providing a full ecosystem that connects learning disabilities specialists, teachers and children’s parents.

Children have access from their home, while parents can consult therapy advancement and doctors, high-quality analytics. We strive to test our products at multiple levels including with a strong methodology and structured specialists validations. Then the game itself is build in respect of fair game rules without violence and in respect of clean game mechanics.

June 1 2017

Seed Investment

Getting the wheel rolling is a priority for Oppimi, now that core team is set up. We found in Pu-Ying Olicom the right investor, to make real things happen. We were looking for active investors that can help us extend our network, especially on China market. Great fit with Pu-Ying Olicom, who are very active in leveraging our entry into Asian market and accelerating research and development.

See more of our achievments

NEWS

Outputs of AIRIPA Congress

Oppimi Group & Beijing University Collaboration

Oppimi Group and Oppimi China are proud to announced a three-year research partnership with Beijing universities to unlock the potential of digital therapeutics in dyslogographia, dysgraphia applied to Chinese characters.

Capital increase to support second phase of clinical piloting

Oppimi Group, digital innovator in the field of Clinically validated tools for diagnosing and treating learning disabilities, announces a capital increase through private placement with Wygu Investment Holdings Co. Limited. Oppimi Group announces a capital increase in the form of a private placement. This capital increase by Wygu Investment Holdings Co. Limited comes 12 months […]

ALL NEWS

Contact Us

Having questions, need more information, interested in a partnership, please hit the button below

Request Feedback